Skip to main navigation Skip to search Skip to main content

Evaluating LRT for Post-Market Surveillance of Adverse Events

Project: Research

Project Details

StatusFinished
Effective start/end date09/24/20 → 09/23/22

Funding

  • US Food and Drug Administration: $527,735.00